Mark R. Schleiss

8.9k total citations · 2 hit papers
209 papers, 6.1k citations indexed

About

Mark R. Schleiss is a scholar working on Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark R. Schleiss has authored 209 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Epidemiology, 81 papers in Infectious Diseases and 27 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark R. Schleiss's work include Cytomegalovirus and herpesvirus research (171 papers), Herpesvirus Infections and Treatments (113 papers) and Parvovirus B19 Infection Studies (66 papers). Mark R. Schleiss is often cited by papers focused on Cytomegalovirus and herpesvirus research (171 papers), Herpesvirus Infections and Treatments (113 papers) and Parvovirus B19 Infection Studies (66 papers). Mark R. Schleiss collaborates with scholars based in United States, Australia and United Kingdom. Mark R. Schleiss's co-authors include Alistair McGregor, Maxim C.‐J. Cheeran, James R. Lokensgard, Michael A. McVoy, Elizabeth C. Swanson, David I. Bernstein, Stanley A. Plotkin, Nigel Bourne, Sallie R. Permar and Craig J. Bierle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mark R. Schleiss

203 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy

2017 523 citations Karen B. Fowler, Gail J. Harrison et al. profile →
Congenital hearing loss

2017 341 citations Mark R. Schleiss et al. profile →

Peers

Countries citing papers authored by Mark R. Schleiss

Since Specialization

Citations

This map shows the geographic impact of Mark R. Schleiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Schleiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Schleiss more than expected).

Fields of papers citing papers by Mark R. Schleiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Schleiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Schleiss. The network helps show where Mark R. Schleiss may publish in the future.

Co-authorship network of co-authors of Mark R. Schleiss

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Schleiss. A scholar is included among the top collaborators of Mark R. Schleiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Schleiss. Mark R. Schleiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Replication-deficient whole-virus vaccines against cytomegalovirus induce protective immunity in a guinea pig congenital infection model 2025 ·Journal of Virology ·Mark R. Schleiss, Claudia Fernández-Alarcón, Craig J. Bierle, Adam P. Geballe, (unknown), (unknown), (unknown), Mark Blackstad, Jian Ben Wang, Michael A. McVoy	1
2	A vaccine against cytomegalovirus: how close are we? 2025 ·Journal of Clinical Investigation ·Sallie R. Permar, Mark R. Schleiss, S. A. Plotkin	12
3	Beyond hearing loss: exploring neurological and neurodevelopmental sequelae in asymptomatic congenital cytomegalovirus infection 2025 ·Pediatric Research ·Meghan R. Swanson, Lauren D Haisley, William B. Dobyns, Mark R. Schleiss	1
4	The urgent search for predictive biomarkers in the emerging era of universal congenital cytomegalovirus screening 2025 ·Philosophical Transactions of the Royal Society B Biological Sciences ·Mark R. Schleiss	0
5	Analysis of Dried Blood Spot and Saliva PCR Screening for Detection of Congenital Cytomegalovirus Infection Informs Implementation of a Novel Universal Newborn Screening Program 2024 ·American Journal of Obstetrics and Gynecology ·Daniel V. Landers, Erin Osterholm, (unknown), Tina C. Huang, Nelmary Hernandez-Alvarado, (unknown), (unknown), Mark R. Schleiss	1
6	Human cytomegalovirus in breast milk is associated with milk composition and the infant gut microbiome and growth 2024 ·Nature Communications ·Kelsey E. Johnson, Nelmary Hernandez-Alvarado, Mark Blackstad, Timothy Heisel, (unknown), David A. Fields, Elvira Isganaitis, (unknown), Dan Knights, Eric F. Lock, Michael C. Rudolph, Cheryl A. Gale, Mark R. Schleiss, Frank W. Albert, Ellen W. Demerath, Ran Blekhman	3
7	Updated National and State-Specific Prevalence of Congenital Cytomegalovirus Infection, United States, 2018-2022 2024 ·Journal of Public Health Management and Practice ·Chelsea S. Lutz, Mark R. Schleiss, Karen B. Fowler, Tatiana M. Lanzieri	7
8	Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023) 2024 ·Vaccines ·Mark R. Schleiss, Chelsea M. Crooks, (unknown), (unknown), (unknown), (unknown), Sallie R. Permar, S. A. Plotkin, Rajeev Gautam	7
9	968. Universal Newborn Testing for Congenital Cytomegalovirus (cCMV) Infection Comes of Age: Clinical Sensitivity of Screening Tests and Infant Outcomes in a cCMV Screening Study in Minnesota 2023 ·Open Forum Infectious Diseases ·Mark R. Schleiss, Erin Osterholm, Nelmary Hernandez-Alvarado, (unknown), (unknown), Abbey Sidebottom, (unknown), Sheila C. Dollard, Tatiana M. Lanzieri	1
10	Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV 2023 ·Open Forum Infectious Diseases ·Jayne Ellis, Ananta Bangdiwala, Caleb P Skipper, Lillian Tugume, (unknown), (unknown), Katelyn A Pastick, Kenneth Ssebambulidde, Bożena M Morawski, Abdu K Musubire, Mark R. Schleiss, David Moore, Joseph N Jarvis, David R. Boulware, David B. Meya, Barbara Castelnuovo	3
11	Gestational Antibodies to C. pneumoniae, H. pylori and CMV in Women with Preeclampsia and in Matched Controls 2022 ·Maternal and Child Health Journal ·Abdul Wajid, David Todem, Mark R. Schleiss, (unknown), Nigel Paneth	1
12	Diversity of the cochlear and vestibular pathologies in human temporal bones of newborns infected with cytomegalovirus 2022 ·PubMed Central ·Vladimir Tsuprun, Mark R. Schleiss, Sebahattin Cüreoǧlu	2
13	Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report 2021 ·BMC Infectious Diseases ·(unknown), Margaret L. MacMillan, Mark R. Schleiss, (unknown), Jo‐Anne H. Young, Christen L. Ebens	1
14	Charting the life course: Emerging opportunities to advance scientific approaches using life course research 2020 ·SHILAP Revista de lepidopterología ·Heidi A. Hanson, (unknown), Gretchen Bandoli, Brad H. Pollock, Margaret R. Karagas, (unknown), Ann Dozier, Nicole G. Weiskopf, Maureen Monaghan, Ann M. Davis, Elizabeth Eckstrom, Chunhua Weng, Jonathan N. Tobin, Frederick J. Kaskel, Mark R. Schleiss, Peter G. Szilagyi, Carrie Dykes, Dan M. Cooper, Shari L. Barkin	6
15	Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection 2017 ·Clinical and Vaccine Immunology ·Mark R. Schleiss, Sallie R. Permar, Stanley A. Plotkin	79
16	Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization 2017 ·Clinical and Vaccine Immunology ·(unknown), Stuart P. Adler, Mark R. Schleiss, Ravit Arav‐Boger, Gail J. Harrison, Michael A. McVoy	8
17	Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector 2016 ·Clinical and Vaccine Immunology ·Mark R. Schleiss, Ursula Berka, (unknown), (unknown), (unknown), Bastien Mangeat, Elizabeth C. Swanson, (unknown), Nelmary Hernandez-Alvarado, Claudia Fernández-Alarcón, (unknown), Daniel D. Pinschewer, Anders Lilja, Michael G. Schwendinger, Farshad Guirakhoo, Thomas P. Monath, Klaus K. Orlinger	32
18	Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality 2015 ·Vaccine ·Elizabeth C. Swanson, (unknown), Nelmary Hernandez-Alvarado, Claudia Fernández-Alarcón, (unknown), (unknown), Felix Wussow, Don J. Diamond, Mark R. Schleiss	30
19	Non-immune hydrops fetalis caused by herpes simplex virus type 2 in the setting of recurrent maternal infection 2013 ·Journal of Perinatology ·K. Pfister, Mark R. Schleiss, Robyn C. Reed, T. Neville George	8
20	Congenital cytomegalovirus infection: Update on management strategies 2008 ·Current Treatment Options in Neurology ·Mark R. Schleiss	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact